Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Moderna Expands U.S. Manufacturing Capabilities with $140M Investment
Moderna, Inc is expanding its US manufacturing capabilities by onshoring Drug Product production to its Moderna Technology Center MTC in Norwood, Massachusetts This development completes the companys
Eli Lilly to Expand European Footprint with $3B Oral Medicines Plant in Netherlands
Eli Lilly and Company plans to invest $3 billion in a new manufacturing facility in Katwijk, located within the Leiden Bio Science Park in the Netherlands
Eli Lilly Invests $1.2 Billion to Boost Oral Drug Production in Puerto Rico
Eli Lilly and Company has announced plans to invest more than $12 billion to expand and modernise its Lilly del Caribe manufacturing facility in Carolina, Puerto Rico The investment aims to strengthen the companys production
Merck Breaks Ground on $3 Billion Pharmaceutical Manufacturing Center in Virginia
Merck has started construction on a $3 billion Centre of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia The 400,000squarefoot facility is part of Mercks longterm plan to expand domestic
AstraZeneca Announces $4.5B Investment in Virginia Production Facility
AstraZeneca has announced a $45 billion investment in its new manufacturing facility at Rivanna Futures in Albemarle County, Virginia
AbbVie Invests $70 Million to Boost U.S. Biologics Manufacturing & R&D
AbbVie has started construction on a $70 million expansion at its AbbVie Bioresearch Center ABC in Worcester, Massachusetts The centre serves as a hub for biologics research, development, and manufacturing This expansion is part of AbbVies wider
Amgen Strengthens U.S. Footprint with $650M Investment
Amgen has announced a $650 million expansion of its US manufacturing network, aimed at increasing production capacity and integrating advanced technologies throughout its operations
GSK to Invest $30 Billion in R&D and Manufacturing in the United States
GSK plc has announced plans to invest $30 billion across the United States over the next five years in research and development and supply chain infrastructure The investment aims to strengthen GSKs innovation
Gilead Sciences Breaks Ground on $32 Billion U.S. Manufacturing Facility
Gilead Sciences has begun construction on a new Pharmaceutical Development and Manufacturing Technical Development Center NTDC at its headquarters in Foster City, California The fivestorey, 180,000 square foot facility
Johnson & Johnson Expands Operations with $2 Billion North Carolina Facility
Johnson Johnson has confirmed a $2 billion investment to expand its manufacturing presence in the United States This development is part of a wider strategy to increase advanced medicines production
